|
US4275000A
(en)
*
|
1977-08-22 |
1981-06-23 |
National Research Development Corporation |
Peptide macromolecular complexes
|
|
DE3277567D1
(en)
*
|
1981-12-21 |
1987-12-10 |
Titmus Eurocon Kontaktlinsen |
Method for disinfecting and cleaning contact lenses
|
|
US4839345A
(en)
*
|
1985-03-09 |
1989-06-13 |
Nippon Oil And Fats Co., Ltd. |
Hydrated adhesive gel and method for preparing the same
|
|
US5268307A
(en)
*
|
1986-05-15 |
1993-12-07 |
E. I. Du Pont De Nemours And Company |
Preparation of liquid affinity supports for bioaffinity an ion exchange separations
|
|
US5268456A
(en)
*
|
1986-05-15 |
1993-12-07 |
E. I. Du Pont De Nemours And Company |
Bioaffinity and ion exchange separations with liquid exchange supports
|
|
US5306615A
(en)
*
|
1986-05-15 |
1994-04-26 |
E. I. Du Pont De Nemours And Company |
Immunoassays and nucleic acid assays with liquid exchange supports
|
|
US4810638A
(en)
*
|
1986-07-24 |
1989-03-07 |
Miles Inc. |
Enzyme-labeled antibody reagent with polyalkyleneglycol linking group
|
|
US6007817A
(en)
|
1988-10-11 |
1999-12-28 |
University Of Southern California |
Vasopermeability enhancing immunoconjugates
|
|
US5238831A
(en)
*
|
1989-04-28 |
1993-08-24 |
Gist-Brocades |
Stabilization of carboxyl esterase
|
|
KR100204837B1
(ko)
*
|
1989-04-28 |
1999-06-15 |
기스트 브로카데스 나암로제 베노오트하프 |
카르복실 에스테라제의 안정화
|
|
US5240747A
(en)
*
|
1989-05-11 |
1993-08-31 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Process for modifying surfaces of materials
|
|
US5252714A
(en)
*
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
CA2106677A1
(en)
*
|
1991-04-01 |
1992-10-02 |
John C. Cheronis |
Bradykinin antagonists
|
|
US5416191A
(en)
*
|
1991-04-01 |
1995-05-16 |
Cortech, Inc. |
Bradykinin antagonists
|
|
US5547981A
(en)
*
|
1993-03-09 |
1996-08-20 |
Enzon, Inc. |
Taxol-7-carbazates
|
|
KR960701923A
(ko)
*
|
1993-04-27 |
1996-03-28 |
프레드릭 에이. 오우스티스 Ⅲ |
아크릴로니트릴 기재 중합체에 의해 형성된 막(membrane formed by an acrylonitrile-based polymer)
|
|
WO1995000162A1
(en)
*
|
1993-06-21 |
1995-01-05 |
Enzon, Inc. |
Site specific synthesis of conjugated peptides
|
|
US5965566A
(en)
*
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
WO1995011020A1
(en)
*
|
1993-10-20 |
1995-04-27 |
Enzon, Inc. |
2'- and/or 7- substituted taxoids
|
|
US5880131A
(en)
*
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
US5605976A
(en)
*
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
|
US5919455A
(en)
*
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
*
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5446090A
(en)
*
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
PT705298E
(pt)
*
|
1993-12-01 |
2002-07-31 |
Bioartificial Gel Technologies Inc |
Hidrogel a base de albumina
|
|
US5730990A
(en)
*
|
1994-06-24 |
1998-03-24 |
Enzon, Inc. |
Non-antigenic amine derived polymers and polymer conjugates
|
|
US5583114A
(en)
*
|
1994-07-27 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Adhesive sealant composition
|
|
USRE38827E1
(en)
|
1994-07-27 |
2005-10-11 |
3M Innovative Properties Company |
Adhesive sealant composition
|
|
CA2164262A1
(en)
*
|
1995-12-01 |
1997-06-02 |
Charles J. Doillon |
Biostable porous material comprising composite biopolymers
|
|
US7883693B2
(en)
*
|
1995-12-18 |
2011-02-08 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
|
|
US6833408B2
(en)
*
|
1995-12-18 |
2004-12-21 |
Cohesion Technologies, Inc. |
Methods for tissue repair using adhesive materials
|
|
ES2373200T3
(es)
*
|
1995-12-18 |
2012-02-01 |
Angiodevice International Gmbh |
Composiciones de pol�?meros reticulados y métodos para su uso.
|
|
US6458889B1
(en)
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
AU4648697A
(en)
*
|
1996-09-23 |
1998-04-14 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
|
US6566406B1
(en)
*
|
1998-12-04 |
2003-05-20 |
Incept, Llc |
Biocompatible crosslinked polymers
|
|
US8003705B2
(en)
*
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
|
US20090324721A1
(en)
*
|
1996-09-23 |
2009-12-31 |
Jack Kennedy |
Hydrogels Suitable For Use In Polyp Removal
|
|
US6743248B2
(en)
|
1996-12-18 |
2004-06-01 |
Neomend, Inc. |
Pretreatment method for enhancing tissue adhesion
|
|
US20040176801A1
(en)
*
|
1997-03-12 |
2004-09-09 |
Neomend, Inc. |
Pretreatment method for enhancing tissue adhesion
|
|
US20030191496A1
(en)
*
|
1997-03-12 |
2003-10-09 |
Neomend, Inc. |
Vascular sealing device with microwave antenna
|
|
US6371975B2
(en)
|
1998-11-06 |
2002-04-16 |
Neomend, Inc. |
Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
|
|
US6514534B1
(en)
*
|
1998-08-14 |
2003-02-04 |
Incept Llc |
Methods for forming regional tissue adherent barriers and drug delivery systems
|
|
US6818018B1
(en)
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US6500571B2
(en)
|
1998-08-19 |
2002-12-31 |
Powerzyme, Inc. |
Enzymatic fuel cell
|
|
US6458147B1
(en)
|
1998-11-06 |
2002-10-01 |
Neomend, Inc. |
Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
|
|
US6994686B2
(en)
*
|
1998-08-26 |
2006-02-07 |
Neomend, Inc. |
Systems for applying cross-linked mechanical barriers
|
|
NZ510689A
(en)
|
1998-10-16 |
2003-07-25 |
Biogen Inc |
Polymer conjugates of interferon beta-1a and uses
|
|
US7279001B2
(en)
*
|
1998-11-06 |
2007-10-09 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US6949114B2
(en)
|
1998-11-06 |
2005-09-27 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US6899889B1
(en)
|
1998-11-06 |
2005-05-31 |
Neomend, Inc. |
Biocompatible material composition adaptable to diverse therapeutic indications
|
|
US6830756B2
(en)
*
|
1998-11-06 |
2004-12-14 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US20080114092A1
(en)
*
|
1998-12-04 |
2008-05-15 |
Incept Llc |
Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
|
|
CA2394431C
(en)
|
1999-12-16 |
2015-06-30 |
Jane Relton |
Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
|
|
EP1257257B1
(en)
|
2000-02-17 |
2018-10-31 |
Neomend, Inc. |
Method for producing delivery systems using preformed biodegradable polymer compositions
|
|
AU5019901A
(en)
*
|
2000-04-04 |
2001-10-15 |
Bioartificial Gel Technologies Inc. |
Process for the preparation of protein-based hydrogels
|
|
EP1284992A2
(en)
*
|
2000-05-30 |
2003-02-26 |
Viridis Biotech Inc. |
Polyubiquitin based hydrogel and uses thereof
|
|
US7605130B2
(en)
*
|
2002-03-26 |
2009-10-20 |
Medical College Of Ohio |
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
|
|
US7037895B2
(en)
*
|
2001-03-27 |
2006-05-02 |
Medical College Of Ohio |
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
|
|
ATE376020T1
(de)
|
2001-08-22 |
2007-11-15 |
Bioartificial Gel Technologies Inc |
Verfahren zu herstellung von aktivierten polyethylenglykolen
|
|
US20030138975A1
(en)
*
|
2001-12-20 |
2003-07-24 |
Kimberly-Clark Worldwide, Inc. |
Diagnostic signal amplification with proteinoid microspheres
|
|
US7056535B2
(en)
*
|
2001-12-20 |
2006-06-06 |
Kimberly-Clark Worldwide, Inc. |
Triggered release from proteinoid microspheres
|
|
WO2003071986A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
|
US7345150B2
(en)
*
|
2002-03-26 |
2008-03-18 |
Medical University Of Toledo |
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
|
|
US7884068B2
(en)
*
|
2002-03-26 |
2011-02-08 |
Assaly Ragheb A |
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
|
|
JP5156890B2
(ja)
*
|
2002-09-11 |
2013-03-06 |
独立行政法人物質・材料研究機構 |
高分子架橋体及びその製造方法
|
|
WO2004060405A2
(en)
*
|
2002-12-30 |
2004-07-22 |
Angiotech International Ag |
Tissue reactive compounds and compositions and uses thereof
|
|
AU2003300076C1
(en)
*
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
US7351787B2
(en)
*
|
2004-03-05 |
2008-04-01 |
Bioartificial Gel Technologies, Inc. |
Process for the preparation of activated polyethylene glycols
|
|
US8067031B2
(en)
|
2004-04-28 |
2011-11-29 |
Angiodevice International Gmbh |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
|
WO2006016600A1
(ja)
*
|
2004-08-10 |
2006-02-16 |
National Institute For Materials Science |
酒石酸誘導体及び該誘導体により合成された高分子架橋体
|
|
CA2581093C
(en)
|
2004-09-17 |
2014-11-18 |
Angiotech Biomaterials Corporation |
Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
|
|
WO2006086510A2
(en)
*
|
2005-02-09 |
2006-08-17 |
Tyco Healthcare Group Lp |
Synthetic sealants
|
|
JP2008541015A
(ja)
*
|
2005-04-28 |
2008-11-20 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
ナノ粒子コンジュゲート
|
|
JP5628476B2
(ja)
*
|
2005-04-28 |
2014-11-19 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
抗体コンジュゲート
|
|
EP3095467B1
(en)
|
2005-11-23 |
2020-05-06 |
Ventana Medical Systems, Inc. |
Antibody-enzyme conjugate
|
|
US20090227981A1
(en)
*
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
US20090227689A1
(en)
*
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
US20080287633A1
(en)
*
|
2007-05-18 |
2008-11-20 |
Drumheller Paul D |
Hydrogel Materials
|
|
US8067028B2
(en)
*
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
|
EP2396070B1
(en)
|
2009-02-12 |
2024-12-04 |
Incept Llc |
Drug delivery through hydrogel plugs
|
|
US20100256671A1
(en)
*
|
2009-04-07 |
2010-10-07 |
Biomedica Management Corporation |
Tissue sealant for use in noncompressible hemorrhage
|
|
EP2485687A1
(en)
*
|
2009-10-09 |
2012-08-15 |
Vatrix Medical, Inc. |
In vivo chemical stabilization of vulnerable plaque
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
CA2865879A1
(en)
|
2012-02-29 |
2013-09-06 |
Toray Industries, Inc. |
Inhibitory agent for body cavity fluid accumulation
|
|
WO2020264188A1
(en)
|
2019-06-26 |
2020-12-30 |
Davol Inc. |
Reactive dry powdered hemostatic materials comprising a nucleophile and a multifunctional modified polyethylene glycol based crosslinking agent
|
|
WO2021189024A1
(en)
|
2020-03-20 |
2021-09-23 |
Bard Peripheral Vascular, Inc. |
Reactive hydrogel forming formulations and related methods
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
|
MX2023007767A
(es)
|
2020-12-28 |
2023-07-07 |
Davol Inc |
Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.
|